These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32161512)

  • 1. The burden of Japanese encephalitis, the catch-up vaccination campaign, and health service providers' perceptions in Myanmar: 2012-2017.
    Win AYN; Wai KT; Harries AD; Kyaw NTT; Oo T; Than WP; Lin HH; Lin Z
    Trop Med Health; 2020; 48():13. PubMed ID: 32161512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High vaccination coverage, inadequate knowledge and high vector density: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
    Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
    F1000Res; 2020; 9():6. PubMed ID: 33014343
    [No Abstract]   [Full Text] [Related]  

  • 3. High vaccination coverage and inadequate knowledge: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
    Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
    F1000Res; 2020; 9():6. PubMed ID: 33014342
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha.
    Kshatri JS; Pattnaik M; Badaik G; Choudhary HR; Mansingh A; Pati S; Bhattacharya D
    J Family Med Prim Care; 2022 May; 11(5):1798-1803. PubMed ID: 35800514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of dengue, source reduction measures, and serotype patterns in Myanmar, 2011 to 2015-R2.
    Oo PM; Wai KT; Harries AD; Shewade HD; Oo T; Thi A; Lin Z
    Trop Med Health; 2017; 45():35. PubMed ID: 29118655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of Japanese Encephalitis mortality and morbidity: A systematic review and modeling analysis.
    Cheng Y; Tran Minh N; Tran Minh Q; Khandelwal S; Clapham HE
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010361. PubMed ID: 35613183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
    Moore SM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors and spatiotemporal distribution of Japanese encephalitis after vaccination campaign in Guizhou Province, China (2004-2016).
    Zhao S; Li Y; Fu S; Liu M; Li F; Liu C; Yu J; Rui L; Wang D; Wang H
    BMC Infect Dis; 2021 Nov; 21(1):1172. PubMed ID: 34809606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization.
    Lopez AL; Raguindin PF; Aldaba JG; Avelino F; Sy AK; Heffelfinger JD; Silva MWT
    Int J Infect Dis; 2021 Jan; 102():344-351. PubMed ID: 33127505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological situation of Japanese encephalitis in Nepal.
    Bista MB; Shrestha JM
    JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coverage evaluation survey of JE vaccination in two districts of Karnataka.
    Kumar KR; Basha R; Harish BR; Sanjay TV; Vinay M; Prabhu S; Babu R
    J Commun Dis; 2010 Sep; 42(3):179-84. PubMed ID: 22471181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers.
    Carias C; Hills SL; Kahn EB; Adhikari BB; Fischer M; Meltzer MI
    Vaccine; 2020 Apr; 38(17):3351-3357. PubMed ID: 32169391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan.
    Nanishi E; Hoshina T; Sanefuji M; Kadoya R; Kitazawa K; Arahata Y; Sato T; Hirayama Y; Hirai K; Yanai M; Nikaido K; Maeda A; Torisu H; Okada K; Sakai Y; Ohga S
    Clin Infect Dis; 2019 May; 68(12):2099-2104. PubMed ID: 30252025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Japanese encephalitis among adults 40 years of age or older in northern China: Epidemiological and clinical characteristics.
    Wu D; Chen X; Liu W; Fu S; Li F; Liang G; Yang G; Zheng H; Li J; Yin Z; Li Y; Wang H
    Transbound Emerg Dis; 2021 Nov; 68(6):3415-3423. PubMed ID: 33283432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Grabowsky M; Nobiya T; Selanikio J
    Trop Med Int Health; 2007 Jul; 12(7):815-22. PubMed ID: 17596247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005-2021.
    Zhang WX; Zhao S; Pan C; Zhou Y; Wang C; Rui L; Du J; Wei TT; Liu YQ; Liu M; Lu QB; Cui F
    J Virus Erad; 2024 Mar; 10(1):100366. PubMed ID: 38586471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.